These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10692092)

  • 21. The EWA (estrogen in women with atherosclerosis) study: a randomized study of the use of hormone replacement therapy in women with angiographically verified coronary artery disease. Characteristics of the study population. Effects on lipids and lipoproteins.
    Os I; Hofstad AE; Brekke M; Abdelnoor M; Nesheim BI; Jacobsen AF; Birkeland K; Larsen A; Midtbo K; Westheim A
    J Intern Med; 2000 Apr; 247(4):433-41. PubMed ID: 10792556
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of hormone replacement therapy on lipoprotein(a) and lipid levels in postmenopausal women. Influence of various progestogens and duration of therapy.
    Kim CJ; Min YK; Ryu WS; Kwak JW; Ryoo UH
    Arch Intern Med; 1996 Aug 12-26; 156(15):1693-700. PubMed ID: 8694668
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transforming growth factor (TGF)-beta1 inversely related to vascular cell adhesion molecule-1 in postmenopausal women with coronary artery disease. A possible mechanism for the putative cardioprotective role of TGF-beta1?
    Os I; Djurovic S; Seljeflot I; Berg K
    J Intern Med; 2002 Mar; 251(3):223-7. PubMed ID: 11886481
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Continuous versus cyclical transdermal oestrogen replacement therapy in postmenopausal women: effects on lipoprotein(a) and nitric oxide levels.
    Serin IS; Aygen EM; Başbuğ M; Saraymen R; Narin F; Tayyar M
    Aust N Z J Obstet Gynaecol; 2001 Nov; 41(4):447-9. PubMed ID: 11787924
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of 17beta-oestradiol on blood pressure of postmenopausal women at high vascular risk.
    Angerer P; Störk S; von Schacky C
    J Hypertens; 2001 Dec; 19(12):2135-42. PubMed ID: 11725155
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An examination of the effect of combined cyclical hormone replacement therapy on lipoprotein(a) and other lipoproteins.
    Haines CJ; Chung TK; Masarei JR; Tomlinson B; Lau JT
    Atherosclerosis; 1996 Jan; 119(2):215-22. PubMed ID: 8808498
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transdermal oestradiol gel in the treatment of the climacterium: a comparison with oral therapy.
    Hirvonen E; Lamberg-Allardt C; Lankinen KS; Geurts P; Wilén-Rosenqvist G
    Br J Obstet Gynaecol; 1997 Nov; 104 Suppl 16():19-25. PubMed ID: 9389779
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma concentrations of Lp(a) lipoprotein and TGF-beta1 are altered in preeclampsia.
    Djurovic S; Schjetlein R; Wisløff F; Haugen G; Husby H; Berg K
    Clin Genet; 1997 Nov; 52(5):371-6. PubMed ID: 9520129
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of estrogen-progestin hormonal replacement therapy on plasma antithrombin III of postmenopausal women.
    Bonduki CE; Lourenço DM; Baracat E; Haidar M; Noguti MA; da Motta EL; Lima GR
    Acta Obstet Gynecol Scand; 1998 Mar; 77(3):330-3. PubMed ID: 9539282
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment with hormone replacement therapy lowers remnant lipoprotein particles in healthy postmenopausal women: results from a randomized trial.
    Ossewaarde ME; Dallinga-Thie GM; Bots ML; van der Schouw YT; Rabelink TJ; Grobbee DE; Westerveld HT
    Eur J Clin Invest; 2003 May; 33(5):376-82. PubMed ID: 12713450
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma leptin in postmenopausal women with coronary artery disease: effect of transdermal 17beta-estradiol and intermittent medroxyprogesterone acetate.
    Os I; Os A; Abdelnoor M; Larsen A; Birkeland K; Westheim A
    Climacteric; 2003 Sep; 6(3):204-10. PubMed ID: 14567768
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison between 1 year oral and transdermal oestradiol and sequential norethisterone acetate on circulating concentrations of leptin in postmenopausal women.
    Laivuori H; Koistinen HA; Karonen SL; Cacciatore B; Ylikorkala O
    Hum Reprod; 2001 Aug; 16(8):1632-5. PubMed ID: 11473954
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term effects of oral and transdermal hormone replacement therapy on plasma homocysteine levels.
    Chiantera V; Sarti CD; Fornaro F; Farzati A; De Franciscis P; Sepe E; Borrelli AL; Colacurci N
    Menopause; 2003; 10(4):286-91. PubMed ID: 12851511
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Plasma levels of total cholesterol, LDL-cholesterol, and HDL-cholesterol in postmenopausal women during 12 months' oral administration of dydrogesterone or medroxyprogesterone combined with continuous transdermal supplementation of 17beta-estradiol].
    Milewicz T; Kostecka A; Rogatko I; Sztefko K; Kwiatkowska-Panek E; Radowick S; Krzysiek J
    Przegl Lek; 2007; 64(2):65-9. PubMed ID: 17892034
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term influence of different postmenopausal hormone replacement regimens on serum lipids and lipoprotein(a): a randomised study.
    Hänggi W; Lippuner K; Riesen W; Jaeger P; Birkhäuser MH
    Br J Obstet Gynaecol; 1997 Jun; 104(6):708-17. PubMed ID: 9197875
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fibrinolysis and lipoprotein(a) in women with coronary artery disease. Influence of hormone replacement therapy.
    Falcó C; Tormo G; Estellés A; España F; Tormo E; Gilabert J; Velasco JA; Aznar J
    Haematologica; 2001 Jan; 86(1):92-8. PubMed ID: 11146577
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biological effects of hormone replacement therapy in relation to serum estradiol levels.
    Yasui T; Uemura H; Tezuka M; Yamada M; Irahara M; Miura M; Aono T
    Horm Res; 2001; 56(1-2):38-44. PubMed ID: 11815726
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hormone replacement therapy in postmenopausal women with specific risk factors for coronary artery disease.
    van der Mooren MJ; Mijatovic V; van Baal WM; Stehouwer CD
    Maturitas; 1998 Sep; 30(1):27-36. PubMed ID: 9819780
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hormone replacement therapy and distensibility of carotid arteries in postmenopausal women: a randomized, controlled trial.
    Angerer P; Kothny W; Störk S; von Schacky C
    J Am Coll Cardiol; 2000 Nov; 36(6):1789-96. PubMed ID: 11092645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Different effects of transdermal and oral hormone replacement therapy on the renin-angiotensin system, plasma bradykinin level, and blood pressure of normotensive postmenopausal women.
    Ichikawa J; Sumino H; Ichikawa S; Ozaki M
    Am J Hypertens; 2006 Jul; 19(7):744-9. PubMed ID: 16814131
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.